ROLE OF POTENTIAL CLINICAL PHARMACIST IN THE MANAGEMENT OF TYPE-2 DIABETES MELLITUS

Background Type-2 dabetes mellitus (T2DM) begins more moderately, as shortage of insulin is caused by an imbalance in insulin levels and response. The most prevalent causes of resistance to insulin are aging and obesity. By considering HbA1c, this study investigates the effects of potential clinical pharmacist (intern student) intervention on diabetic management among patients undergoing counselling and the control group. Methods A prospective longitudinal study was conducted among adults (≥18 years) with T2DM between August, 2024 and January, 2025. Participants who provided informed consent with T2DM were included, while those with type 1 diabetes, gestational diabetes, or severe organ dysfunction were excluded. Results The study found that over six months, the potential clinical pharmacist approach greatly enhanced glucose control in patients with T2DM (p < .001). Compared to patients who underwent pharmacist counselling showed a greater decrease in their HbA1c values (p < .001) when compared to no intervention (control) group. Further, medication adherence and KAP scores increased considerably among counseled patients. Compared to patients in control group, those in intervention group saw a greater decrease in their HbA1c values (p < .001).